Photopharmics
Manufacturing · Utah, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3451 N Triumph Blvd Ste 201, Lehi, Utah,...Phone Number
(801) 770-6960Website
www.photopharmics.comRevenue
<$5 MillionIndustry
About Photopharmics
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson's, offering a new therapeutic approach that enhances quality of life without major side effects. Future plans include expanding their innovative solutions to Alzheimer's and other neurodegenerative conditions.Explore more
Photopharmics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Photopharmics
Compare insights from companies similar to Photopharmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Photopharmics Tech Stack
A closer look at the technologies used by Photopharmics
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Photopharmics
Sign Up For FreeTo access detailed company insights
PhotoPharmics is a pioneer in specialized phototherapy aimed at treating neurodegenerative diseases, particularly Parkinson's disease. Their personalized at-home device, Celeste specialized phototherapy, addresses both motor and non-motor symptoms, showing promising results in clinical studies. The company targets individuals living with Parkinson'... Read More
